Erasca (ERAS) Net Equity Issued and Repurchased (2020 - 2026)
Erasca's (ERAS) quarterly Net Equity Issued and Repurchased came in at $258.8 million in Q1 2026, up 248.16% on a QoQ basis from -$174.6 million in Q4 2024.
Erasca (ERAS) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Erasca (ERAS) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $258.8 million in Q1 2026.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $258.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200.0 million (changed N/A YoY) and the FY2024 annual result came in at $21.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased advanced to $258.8 million in Q1 2026, from -$174.6 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $258.8 million in Q1 2026 to a low of -$174.6 million in Q4 2024.
- A 3-year average of $50.0 million and a median of $58.0 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Erasca | 6.43 Bn | 6.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 258.75 Mn |
| Mar 31, 2026 | 258.75 Mn |
| Dec 31, 2024 | -174.64 Mn |
| Dec 31, 2024 | -174.64 Mn |
| Sep 30, 2024 | 21.00 Mn |
| Sep 30, 2024 | 21.00 Mn |
| Dec 31, 2022 | 94.90 Mn |
| Dec 31, 2022 | 94.90 Mn |
| Mar 31, 2021 | 119.39 Mn |
| Mar 31, 2021 | 119.39 Mn |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 11.97 Mn |
| Sep 30, 2020 | 11.97 Mn |
| Jun 30, 2020 | -12.00 Mn |
| Jun 30, 2020 | -12.00 Mn |